"That is along the lines of the Canadian regulator"
In the USA, with their regulator, that's the FDA, the closest to that is what they call a Phase IV trial. Post conditional release where people who have been treated and meet the previous trial criteria have their response and other data collected. The FDA then requires that data within a specified time frame to consider full release.
I would expect Mesoblast would receive full revenues, the product has been conditionally released to all people in need.
And that is if the FDA needs more patient data, that is not what was asked for it would seem.
- Forums
- ASX - By Stock
- MESO Nasdaq update
"That is along the lines of the Canadian regulator"In the USA,...
-
- There are more pages in this discussion • 256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.105(7.58%) |
Mkt cap ! $1.587B |
Open | High | Low | Value | Volume |
$1.39 | $1.50 | $1.38 | $3.516M | 2.453M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21880 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 41977 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5300 | 1.485 |
7 | 12440 | 1.480 |
4 | 16406 | 1.475 |
6 | 30442 | 1.470 |
5 | 29764 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 15514 | 4 |
1.495 | 12138 | 6 |
1.500 | 242336 | 21 |
1.505 | 165102 | 7 |
1.510 | 32151 | 7 |
Last trade - 12.23pm 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online